Clinical trial
Toradol to Reduce Ureteroscopic Symptoms Trial
NCT03111381 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Toradol to Reduce Ureteroscopic Symptoms Trial
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- June 1, 2020
- Enrollment
- 94 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney diseases, kidney stone, pain, postoperative, urinary lithiasis